RE-BVS – Piemonte Repository

Sfoglia per AUTORE
HOU J
Collezione AOU Città della Salute di Torino

Items : 6

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis. in Clinical journal of the American Society of Nephrology : CJASN / Clin J Am Soc Nephrol. 2024 Apr 1;19(4):438-451. doi: 10.2215/CJN.0000000000000398. Epub 2024 Jan 23

2024
AOU Città della Salute di Torino

Joh K; Hou J; Hernandez LH; Eldin K; Cornea V; Comstock JM; Becker JU; Barreca A; Bajema I; Avila-Casado C; Maixnerova D; Tesar V; Liu ZH; Shi S; Zhang H; Materassi M; Santoro D; Conti G; Fujimoto S; Takafumi I; Yokoo T; Tsuboi N; Pecoraro C; Pohl M; Hackl A; Weber LT; Koskela M; Nuutinen M; Nakatani S; et alii...

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 Jun;28(6):284-293. doi: 10.1016/j.jtct.2022.03.019. Epub 2022 Mar 17.

2022
AOU Città della Salute di Torino

Silberman R; Iftikhar R; Abonour R; Moreau P; Otero PR; Malhotra P; Biran N; Callander N; Janakiram M; Mohty M; Prince M; Beksac M; Chaudhry M; Aljurf M; Costa L; Hou J; Schriber J; Quach H; Einsele H; Cook G; Gay F; Costello C; Poudyal BS; Cowan A; Garfall A; Lonial S; Kumar A; Shah N; Kansagra A; et alii...

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. in The Lancet. Oncology / Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7.

2021
AOU Città della Salute di Torino

Moreau P; Kumar SK; San Miguel J; Davies F; Zamagni E; Bahlis N; Ludwig H; Mikhael J; Terpos E; Schjesvold F; Martin T; Yong K; Durie BGM; Facon T; Jurczyszyn A; Sidana S; Raje N; van de Donk N; Lonial S; Cavo M; Kristinsson SY; Lentzsch S; Hajek R; Anderson KC; João C; Einsele H; Sonneveld P; Engelhardt M; Fonseca R; et alii...

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Aug 10;36(23):2405-2412. doi: 10.1200/JCO.2017.76.8853. Epub 2018 May 31.

2018
AOU Città della Salute di Torino

Salles G; Cheson BD; Vermeulen J; Balasubramanian S; Schaffer M; Damle RN; Wang SS; Gartenberg GJ; Deshpande S; Caballero D; Morton J; Jurczak W; Radford J; Spencer A; Vitolo U; Martin P; Lill M; Yacoub A; Hou JZ; Hess G; Trotman J; Fowler NH; Schuster SJ; Gopal AK; Gopal AK; Schuster SJ; Fowler NH; Trotman J; Hess G; et alii...

Second primary malignancies in multiple myeloma: an overview and IMWG consensus. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606.

2017
AOU Città della Salute di Torino

Musto P; Anderson KC; Attal M; Richardson PG; Badros A; Hou J; Comenzo R; Du J; Durie BGM; San Miguel J; Einsele H; Chen WM; Garderet L; Pietrantuono G; Hillengass J; Kyle RA; Moreau P; Lahuerta JJ; Landgren O; Ludwig H; Larocca A; Mahindra A; Cavo M; Mazumder A; McCarthy PL; Nouel A; Rajkumar SV; Reiman A; Riva E; et alii...

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.

2016
AOU Città della Salute di Torino

Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; et alii...